Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).

NCT01582763 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT01582763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01582763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Completed
Start date
May 1, 2012
Completion date
December 2, 2024
Enrollment
2,000 (actual)
Sites
138

Conditions

As the registry lists them; a condition with its own page is linked.

guillain-barré syndrome, miller fisher syndrome